Corporate Alembic Pharmaceuticals Limited April 25, 2026 Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 25, 2026, titled “Alembic Pharmaceuticals Limited receives USFDA Final Approval for Fingolimod Capsules 0.5 mg.”. |SUBJECT: Press Release Post navigation IndusInd Bank Limited Axis Bank Limited Related Posts Oil & Natural Gas Corporation Limited Oil & Natural Gas Corporation Limited has informed the Exchange about Clarification with respect to… March 4, 2026 Mangalam Worldwide Limited Mangalam Worldwide Limited has informed the Exchange about regarding typographical error in intimation dated May… May 2, 2026 Sammaan Capital Limited Sammaan Capital Limited has informed the Exchange regarding ‘Further to our intimation dated April 1,… April 7, 2026 Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Oil & Natural Gas Corporation Limited Oil & Natural Gas Corporation Limited has informed the Exchange about Clarification with respect to… March 4, 2026
Mangalam Worldwide Limited Mangalam Worldwide Limited has informed the Exchange about regarding typographical error in intimation dated May… May 2, 2026
Sammaan Capital Limited Sammaan Capital Limited has informed the Exchange regarding ‘Further to our intimation dated April 1,… April 7, 2026